The University of Wisconsin System was awarded a $1,555,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ASTROCYTE DYSFUNCTION IN RETT SYNDROME". The award, effective March 1, 2025, supports a comprehensive research project spanning nearly 4 years, with a final completion date of February 28, 2029. The federal grant funding will enable the University of Wisconsin - Madison to carry out innovative scientific studies focused on gaining a better understanding of astrocyte dysfunction in the context of Rett syndrome, a rare neurological disorder. As the prime awardee, the University of Wisconsin System will lead this research effort, drawing upon its extensive expertise in areas such as biological sciences, medicine, and translational research to advance knowledge and treatment approaches for this condition.
Generated 3/4/25, 4:47 AM